ClinicalTrials.gg
Enrolling by invitationNCT07622732DDUpdated Aug 21, 2026

Biofeedback for Women With Dyssynergic Defecation (DD)

An interventional study of Lifestyle management in form of stretching positions and patient's education position of defecation in Dyssenergic Defecation and Straining, Hard Stools, Incomplete Evacuation, sponsored by Ahram Canadian University. Enrolling by invitation at 1 site in Egypt. Open to female participants aged 35 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-08-21.

Sponsored by Ahram Canadian University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
58
Allocation
Randomized
Ages
35 Years to 65 Years
Sex
Female
01

Study summary

This research aimed to compare the effect of Biofeedback (BFB) versus Lifestyle management in form of stretching positions and patient's education position of defecation, in addition to rectal massage, and anal dilators among Dyssynergic Defecation (DD) in Females. It is common and affects up to one half of patients with chronic constipation. This acquired behavioral problem is due to the inability to coordinate the abdominal and pelvic floor muscles to evacuate stools

Read the detailed description

A randomized controlled trial will be conducted on 58 female participants aged 35-65 years, their BMI 30-34 kg/m2, they are suffering from DD, Diagnostic criteria for functional defecation disorders include those for functional constipation, namely two or more of 6 symptoms present for the last 3 months with an onset more than 6 months in the past; the symptoms are: straining, lumpy or hard stools, sensation of incomplete evacuation, sensation of anorectal obstruction/blockage, or manual maneuvers to facilitate defecation, or less than 3 bowel movements per week. All the included patients will have selected to be unresponsive to dietary modification, life style modification, and laxatives for a period of at least 3 months. The control Group (n=30), receiving Lifestyle management in form of stretching positions and patient's education position of defecation, in addition to rectal massage, and anal dilators, while the study Group (n=30), receiving the same program in addition to BFB. The Patient will receive consecutive 12 sessions at frequency of 2 sessions per week over a period of 6 weeks. The treatment will have done on outpatient basis. During the session, the patient will be instructed to visualize the monitor (pressure traction) to understand the function of the pelvic floor muscles especially to the responses during anal squeezing and straining. During menstruation, the patient will be temporarily withdrawn from the sessions tell the end of menstruation. Primary Outcome Measures: 1- Resting anal pressure. 2-Maximum straining anal pressure during an attempted defecation (bearing down). Time Frame: the questionnaire will be taken at baseline and after 6 weeks of intervention. Description: These variables will be done by using the EMG Biofeedback device: (Gymna Myo 200). This is the primary test to assess the pressure activity and coordination of the rectal and anal muscles. A small, flexible probe will be inserted into the rectum. The test will measure rectal pressure andanal sphincter pressure changes. In DD, it typically shows inadequate pushing force, paradoxical anal sphincter contraction, or insufficient relaxation. Secondary Outcome Measures: 1-Bristol scale: to assess the consistency of the stool. 2- Functional obstructed defecation severity, Modified obstructed defecation score (MODS). Time Frame: the questionnaire will be taken at baseline and after 6 weeks of intervention. Description: the MODS is a sum of individual scores for 7 symptoms and one score for life style alteration. 3- Digital rectal examination (DRE): Assess resting and squeeze tone of the anal sphincter and puborectalis muscles. It is a crucial, cost-effective screening tool that can be performed in the clinic. Identifying dyssynergia in patients with chronic constipation and detecting normal, but not abnormal, sphincter tone. Time Frame: the questionnaire will be taken at baseline and after 6 weeks of intervention. Description: During an attempted defecation maneuver (bearing down), the examiner will normally feel the anal sphincter relax and the perineum descend. In patients with DD, the examiner will may feel the anal sphincter paradoxically contract (tighten) or fail to relax, along with absent or reduced perineal descent. Digital Rectal Examination This evaluation consisted of 3 steps: (1) inspection of the anus and surrounding tissue, (2) testing of perineal sensation and the anocutaneous reflex; and (3) digital palpation and maneuvers to assess anorectal function. With the patient in the left lateral position, and hips flexed to 90°, the anus and surrounding tissue were inspected in good light to check for skin excoriation, skin tags, anal fissure, scars, or hemorrhoids. The perineal sensation then will be assessed by stroking the skin around the anus in a centripetal fashion in all 4 quadrants by using a stick with a cotton bud. A normal response consisted of a brisk contraction of the perianal skin, the anoderm, and the external anal sphincter. This reflex response is termed the anocutaneous reflex. If there is no response with the soft cotton bud, the opposite (wooden) end will be used to provide a more intense sensation. If a response will be evoked with the wooden end but not with the cotton bud end, the response will be categorized as impaired anocutaneous reflex, and if there is no response with either end, the response will be categorized as absent. Next, digital palpation will be performed by slowly advancing a lubricated and gloved index finger into the rectum. The presence of any tenderness, mass, stricture, or stool, and the consistency of the stool, were noted. The resting sphincter tone will be assessed and categorized as either normal, weak (decreased), or increased. The patient then will be asked to squeeze and to hold the squeeze for as long as possible. The squeeze anal tone will be categorized as normal, weak (decreased), or increased. Next, the examiner placed the left hand over the patient's abdomen to assess the push effort. The patient then will be asked to push and bear down as if to defecate. The push effort, the ability to relax the anal sphincter, and the degree of perineal descent will be noted. Each maneuver will be repeated once or twice to ensure that the patient fully understood and complied with the request, and that the responses will be consistent. A normal response consisted of contraction of abdominal muscles along with relaxation of the external anal sphincter and puborectalis muscle and perineal descent. The presence of any 2 of the following findings will be used to clinically diagnose dyssynergia: the inability to contract the abdominal muscles, inability to relax the anal sphincter, a paradoxical contraction of the anal sphincter, or the absence of perineal descent. The EMG Biofeedback will be performed by using rectal probe and using previously described methodology.

Descriptive statistics:

In this study, the descriptive statistics (the mean and the standard deviation) and frequency/percentage for categorical data will be calculated for all subjects in the study to determine the homogeneity of the groups. Frequency/percentage for categorical data.

Analytical statistics:

Data will be analyzed using SPSS. Normality will be assessed using the Shapiro-Wilk test. Baseline comparisons between groups will be performed using independent t-tests or Mann-Whitney U tests as appropriate. A two-way repeated measures ANOVA will be used to evaluate the effects of time (pre- and post-intervention), group (control vs. study), and their interaction on primary and secondary outcomes. For non-normally distributed data, Wilcoxon signed-rank and Mann-Whitney U tests will be applied. A p-value ≤ 0.05 will be considered statistically significant.

02

Conditions studied

  • Dyssenergic Defecation
  • Straining, Hard Stools, Incomplete Evacuation

Keywords

  • Dyssynergic defecation, biofeedback. Maximum straining anal pressure,
  • Bristol scale, Functional obstructed defecation severity, Modified obstructed defecation score,
03

In context

Lead sponsor

Ahram Canadian University is the lead sponsor of 71 studies on the registry; 42 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
35 Years to 65 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Female patients aged between 35-65 years, their 30-34 kg/m2, they are suffering from DD, have ability to perform BFB, and cooperative and capable of providing . namely two or more of 6 symptoms present for the last 3 months with an onset more than 6 months in the past; the symptoms are: straining, lumpy or hard stools, sensation of incomplete evacuation, sensation of anorectal obstruction/blockage, or manual manoeuvres to facilitate defecation, or less than 3 bowel movements per week. All the included patients will have selected to be unresponsive to dietary modification, life style modification, and laxatives for a period of at least 3 months.

Exclusion criteria

Exclusion Criteria:

  • Significant anatomical issues such as a large rectocele, full rectal prolapse, active anal fissures, severe internal anal sphincter injuries, or anorectal neoplasia, history of recent anal region surgery (e.g., within the last 6 months), history of previous gastrointestinal, spinal, or pelvic surgery, neurological diseases that affect bowel function, such as multiple sclerosis, stroke, spinal cord injury, or Parkinson's disease, severe cardiac, renal, or (COPD), inflammatory bowel disease (Crohn's disease or ulcerative colitis), diabetes mellitus, or thyroid dysfunction. Use of opioids within a specified recent period (e.g., the previous 2 weeks or not on a stable dose). Use of medications known to cause constipation or interfere with the study, such as certain antidepressants or analgesics. Recent history (e.g., within 6 months) of Botox injections for pelvic floor issues. Pregnancy, Impaired cognition or mental health issues (e.g., severe depression, psychotic disorders, cognitive disability) that would prevent understanding and cooperation with the treatment. Alternating patterns of constipation and diarrhea, which may indicate Irritable Bowel Syndrome (IBS) without a clear constipation subtype.
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

COPD

Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
58 participants (estimated)

Study arms

  • Experimental
    Experimental: Traditional Group (Control)

    The control Group (n=30), receiving Lifestyle management in form of stretching positions and patient's education position of defecation, in addition to rectal massage, and anal dilators

    Other: Lifestyle management in form of stretching positions and patient's education position of defecation

  • Active comparator
    Study group

    The study Group (n=30), receiving the same program in addition to Biofeedback (BFB). The Patient will receive consecutive 12 sessions at frequency of 2 sessions per week over a period of 6 weeks

    Other: Lifestyle management in form of stretching positions and patient's education position of defecation

Interventions

  • OtherLifestyle management in form of stretching positions and patient's education position of defecation

    1. Stretching Positions: \*Child's Pose\*\* Reverse Kegel Exercises \*\*\*Supine Piriformis Stretch. 2. Education Defecation Position: patient sit with her knees positioned higher than hips, use a small footstool. Lean forward from the hips and rest your forearms on thighs. 3. Rectal Massage: Using a water-based lubricant and a clean, gloved finger, therapist can gently massage the internal anal sphincter to encourage it to relax. 4. Anal Dilators: patient lie on her side or back with pillows under knees. Apply a generous amount of water-based lubricant to both the dilator and anal area. Ask patient to gently bear down as if passing gas and insert the tip. Pause if she feel the muscle contract or guard, ask her to focus on breathing, and wait for the muscle to soften before inserting it further.Once fully inserted, ask her to breathe in deeply to distend her belly, then exhale while maintaining abdominal distention. Visualize the pelvic floor dropping.

    Also known as: rectal massage, and anal dilators

06

What researchers measure

Primary outcomes

  1. 1- Resting anal pressure. 2-Maximum straining anal pressure during an attempted defecation (bearing down).

    These variables will be done by using the EMG Biofeedback device: (Gymna Myo 200). This is the primary test to assess the pressure activity and coordination of the rectal and anal muscles. A small, flexible probe will be inserted into the rectum. The test will measure rectal pressure and anal sphincter pressure changes, using Millimeters of mercury (mmHg). In DD, it typically shows inadequate pushing force, paradoxical anal sphincter contraction, or insufficient relaxation.

    Time frame: The measurements will be taken at baseline and after 6 weeks of intervention

Secondary outcomes

  1. 1-Bristol scale: to assess the consistency of the stool. 2- Functional obstructed defecation severity, Modified obstructed defecation score (MODS). 3- Digital rectal examination (DRE). 4- Body Mass Index (BMI).

    1. Bristol scale: a medical tool that classifies stool into 7 categories based strictly on shape and consistency, consistency by dividing stool forms into three primary types, \*Constipation (Types 1-2),\*\*Ideal/Normal (Types 3-5),\*\*\*Diarrhea (Types 6-7). 2. (MODS):is a sum of individual scores for 7 symptoms and one score for life style alteration. 1. The Renzi (Modified) ODS Score, The 5 Core Items Measured:Each item is typically graded on a 5-point Likert scale from (0) (Never) to (4) (Always). 2. The Longo ODS Score. 3. (DRE): This evaluation consisted of 3 steps: inspection of the anus and surrounding tissue, (2) testing of perineal sensation and the anocutaneous reflex; and (3) digital palpation and maneuvers to assess anorectal function. 4. Weight and Height will be combined to report BMI in kg/m\^2

    Time frame: The scale / questionnaire will be taken at baseline and after 6 weeks of intervention.

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 21, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07622732
Lead sponsor
Ahram Canadian University
Responsible party
Radwa Mohammed Yehia (Assistant Professor, Ahram Canadian University) — Principal investigator
First posted
Jun 3, 2026
Start date
Jun 15, 2026
Primary completion
Oct 15, 2026 (estimated)
Completion
Nov 1, 2026 (estimated)
Last update
Aug 21, 2026

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion